02:01:37 EST Sun 03 Dec 2023
Enter Symbol
or Name

Login ID:

SEC permanently bans California's Giguiere

2023-04-10 20:34 ET - Street Wire

Also Street Wire (U-KVMD) Kelvin Medical Inc

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Mike Caswell

The U.S. Securities and Exchange Commission has won a permanent ban for Gannon Giguiere, operator of the touting website TheMoneyStreet, for a 2017 scheme on the OTC Markets. The SEC said that Mr. Giguiere, along with a group of Canadians, was behind pump-and-dumps that included a 2017 effort to boost Kelvin Medical Inc., a supposed medical device maker. He and Vancouver's Oliver Lindsay entered manipulative trades in the midst of a promotional campaign run through TheMoneyStreet.

The ban for Mr. Giguiere is contained in a notice of settlement filed in federal court in San Diego on Friday, April 7. The settlement, which requires approval from the judge, permanently bars Mr. Giguiere from penny stocks and from serving as an officer or director of any public company. He must also pay financial penalties, with the judge to determine the amounts.

For Mr. Giguiere, the ban is just part of his punishment for the scheme. He previously pleaded guilty to related criminal charges and received 12 months in jail, a sentence that he completed on Feb. 13, 2023. Prosecutors also won a $187,893 forfeiture order against him. (All figures are in U.S. dollars.) As part of the criminal case, the government seized assets belonging to Mr. Giguiere that it said had been acquired with the proceeds of crime. Those assets included a 2007 Ferrari F12 Berlinetta that the government eventually sold.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2023 Canjex Publishing Ltd. All rights reserved.

Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.